Literature DB >> 8879186

A transformed human tracheal gland cell line, MM-39, that retains serous secretory functions.

M D Merten1, W Kammouni, W Renaud, F Birg, M G Mattéi, C Figarella.   

Abstract

Infection with the wild type SV40 virus was used to transform primary cultures of human tracheal gland serous (HTGS) cells. Over 80 different cell lines were obtained, but the majority had lost some of their epithelial and secretory features. However, one of these cell lines, MM-39, was shown to have conserved the physiologic characteristics of the genuine HTGS cells-i.e., the presence of cytokeratin, expression of cystic fibrosis transmembrane conductance regulator mRNA, a level of secretory leukocyte proteinase inhibitor secretion comparable to that of the native cells (25 +/- 3 ng/10(6) cells/h), and the responsiveness to pharmacological agonists: carbachol (+260 +/- 40%), isoproterenol (+260 +/- 40%), and adenosine 5'-triphosphate (+280 +/- 30%). These characteristics describe a transformed cell line of human tracheal gland cells which has retained the features of the native serous cells. As a result, this cell line appears to be a useful tool for large-scale physiologic and pharmacologic studies of bronchial secretion at the cellular level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879186     DOI: 10.1165/ajrcmb.15.4.8879186

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  8 in total

1.  Contribution of α7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure.

Authors:  Kamel Maouche; Kahina Medjber; Jean-Marie Zahm; Franck Delavoie; Christine Terryn; Christelle Coraux; Stéphanie Pons; Isabelle Cloëz-Tayarani; Uwe Maskos; Philippe Birembaut; Jean-Marie Tournier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

2.  Mucins secreted by a transformed cell line derived from human tracheal gland cells.

Authors:  J M Lo-Guidice; M D Merten; G Lamblin; N Porchet; M C Houvenaghel; C Figarella; P Roussel; J M Perini
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

3.  Pseudomonas aeruginosa quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone inhibits expression of P2Y receptors in cystic fibrosis tracheal gland cells.

Authors:  A Saleh; C Figarella; W Kammouni; S Marchand-Pinatel; A Lazdunski; A Tubul; P Brun; M D Merten
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells.

Authors:  Florence Gaden; Laure Franqueville; Maria K Magnusson; Saw See Hong; Marc D Merten; Leif Lindholm; Pierre Boulanger
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

5.  Salmeterol restores secretory functions in cystic fibrosis airway submucosal gland serous cells.

Authors:  Franck Delavoie; Michael Molinari; Magali Milliot; Jean-Marie Zahm; Christelle Coraux; Jean Michel; Gérard Balossier
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-17       Impact factor: 6.914

6.  Long acting beta2-agonist and corticosteroid restore airway glandular cell function altered by bacterial supernatant.

Authors:  Jean-Marie Zahm; Franck Delavoie; Férial Toumi; Béatrice Nawrocki-Raby; Claire Kileztky; Jean Michel; Gérard Balossier; Malcolm Johnson; Christelle Coraux; Philippe Birembaut
Journal:  Respir Res       Date:  2010-01-20

7.  Abnormal spatial diffusion of Ca2+ in F508del-CFTR airway epithelial cells.

Authors:  Fabrice Antigny; Caroline Norez; Anne Cantereau; Frédéric Becq; Clarisse Vandebrouck
Journal:  Respir Res       Date:  2008-10-30

8.  New microbicidal functions of tracheal glands: defective anti-infectious response to Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Sonia Bastonero; Yannick Le Priol; Martine Armand; Christophe S Bernard; Martine Reynaud-Gaubert; Daniel Olive; Daniel Parzy; Sophie de Bentzmann; Christian Capo; Jean-Louis Mege
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.